Cellular

Longevity2020: Day 5 Recap

On Friday, the Longevity2020 online conference drew to a close, and the final day explored what people can be doing today to address their...

Longevity2020: Day 2 recap

Yesterday at Longevity2020 was all about rejuvenation therapies, bringing together some of the world’s leading luminaries in the fight against aging. Things kicked off with...

Longevity2020: Day 1 recap

The first day of Longevity2020 kicked off yesterday as we welcomed some of the big names in Longevity to the virtual stage. Curated by AgeCurve’s...

BioViva to spin out its R&D and bioinformatics

CEO in the front-line: Liz Parrish talks gene therapy, patient data and funding. From academics and entrepreneurs to engineers and technologists, the battle against aging...

Juvenescence CEO on near-term Longevity breakthroughs

We talk pipeline, trials, raising capital and public company challenges with Juvenescence's Dr Greg Bailey. Longevity.Technology: Longevity is growing as a distinct investment category and Thursday’s...

The quest to define biological age

Prof Steve Horvath, the founder of epigenetic age measurement, talks methylation clocks and the need for standardisation. A key speaker on the subject will be...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Reprogram, rejuvenate, rewind: spinout

Soaking up Longevity - a Stanford University team has rejuvenated aging human cells with a novel protein "bath" and formed a spinout. Researchers at Stanford...

From machines to animals to humans

Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models. “Will you still need me, will you still feed me, when...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

‘Damage-eating’ protein fixes DNA harmed by aging

A toolkit of proteins that can repair breaks in strands of DNA has been discovered by scientists at the Universities of Sheffield and Oxford. DNA...

Two novel anti-aging targets identified

A recent Chinese study has identified two novel anti-aging targets that accelerate aging by suppressing the expression of genes involved in mitochondrial function maintenance: promoting...

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” - seeking investment to evolve world’s smallest syringe...

The Reason behind Longevity: start-up opportunities

We connected with Reason (the person) to get the inside track on hot areas for Longevity R&D.   Longevity.Technology: Advocacy runs through Reason like a...

114 year-old cells converted to pluripotent stem cells

AgeX publishes evidence of supercentenarian cellular age reversal: new paper supports hypothesis of no upper age limit for reprogramming cellular aging. This is big...

Placenta blood and personalised Longevity therapies

The placenta is a reservoir of stem cells with minimal ethical concerns. The establishment of placental stem cell biobanks will enable their use in...

Proving the Longevity potential of NAD+

Talking sirtuins, NAD+ and trials with Elysium Health CEO Eric Marcotulli. When it comes to the world of consumer anti-aging supplements, there are few higher-profile...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

Pathway to Longevity: get rid of zombie cells

Understanding the trigger for cellular senescence could help to forge new treatments for Longevity, stopping aging before it's started. Cellular senescence is a double-edged sword;...

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...